It has been said many times...here and elsewhere that competition is on the ready for any indication...NASH at the present time is in the arena of non-compete...when it comes to an APPROVAL...it has to be our target...at the moment...
HIV is a back-burner subject...We just need the FDA to recognize the safety and later efficacy...to remove DOUBT...that our Molecule doesn't kill people inadvertently...unlike some that currently occupy space on the shelf.